Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 192,327 | 200,596 | 214,054 | 233,871 | 243,619 |
| Receivables | 22,265 | 22,789 | 6,249 | 5,424 | 4,595 |
| TOTAL | $226,291 | $230,783 | $226,765 | $245,979 | $256,728 |
| Non-Current Assets | |||||
| PPE Net | 7,044 | 4,583 | 1,829 | 1,033 | 1,038 |
| Intangibles | 42,480 | 43,270 | 44,060 | 0 | 0 |
| Other Non-Current Assets | 9,241 | 7,487 | 8,061 | 9,559 | 2,072 |
| TOTAL | $58,765 | $55,340 | $53,950 | $10,592 | $3,110 |
| Total Assets | $285,056 | $286,123 | $280,715 | $256,571 | $259,838 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 159 | N/A | N/A |
| Accounts payable and accrued liabilities | 4,475 | 4,660 | 2,419 | 1,337 | 4,683 |
| Accrued Expenses | 7,256 | 11,330 | 7,875 | 4,404 | 3,441 |
| TOTAL | $12,166 | $16,483 | $11,158 | $6,372 | $8,543 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 136 | 162 | 182 | 196 | 217 |
| Other Non-Current Liabilities | 11,821 | 6,860 | 9,205 | 7,741 | 1,442 |
| TOTAL | $18,123 | $14,059 | $16,995 | $7,728 | $1,384 |
| Total Liabilities | $30,289 | $32,986 | $28,153 | $14,100 | $9,927 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,216 | 37,200 | 37,191 | 34,852 | 34,328 |
| Common Shares | 95 | 8 | 95 | 87 | 87 |
| Retained earnings | -90,296 | -105,989 | -108,585 | -93,472 | -88,915 |
| Other shareholders' equity | -30,867 | -13,969 | -8,051 | -8,540 | -2,054 |
| TOTAL | $254,767 | $253,137 | $252,562 | $242,471 | $249,911 |
| Total Liabilities And Equity | $285,056 | $286,123 | $280,715 | $256,571 | $259,838 |